Collegium Pharmaceutical (COLL) Goodwill (2022 - 2026)

Collegium Pharmaceutical has reported Goodwill for 5 years, with the latest figure at $190.2 million in Q2 2026.

• On a quarterly basis, Goodwill rose 28.55% year-over-year to $190.2 million in Q2 2026; TTM through Jun 2026 was $190.2 million, a 28.55% increase from a year earlier, with the FY2025 full-year figure at $145.9 million, down 10.11% from the prior year.
• Goodwill was $190.2 million for Q2 2026 at Collegium Pharmaceutical, up from $145.9 million in the prior quarter.
• The five-year high for Goodwill was $190.2 million in Q2 2026, with the low at $130.1 million in Q2 2022.
• Average Goodwill over 5 years is $142.4 million, with a median of $133.9 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Goodwill fell 10.11% in 2025, then rose 28.55% in 2026.
• Over 5 years, Goodwill stood at $133.7 million in 2022, then rose by 0.12% to $133.9 million in 2023, then gained by 21.27% to $162.3 million in 2024, then fell by 10.11% to $145.9 million in 2025, then surged by 30.33% to $190.2 million in 2026.
• The last three Goodwill figures came in at $190.2 million (Q2 2026), $145.9 million (Q1 2026), and $145.9 million (Q4 2025), per Business Quant data.